Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages
Fig 8
Macrophage subtypes of anti-PD-1 resistance in NSCLC.
Gene set enrichment analysis of anti-PD 1 treatment for NSCLC showed that patients in complete remission (CR) and partial remission (PR) compared with those in patients with progressive disease (PD).